Background -Spectral characteristics of breath sounds in asthma and chronic obstructive pulmonary disease (COPD) have not previously been compared, although the structural differences in these disorders might be reflected in breath sounds. Methods -Flow standardised inspiratory breath sounds in patients with COPD (n = 17) and stable asthma (n= 10) with significant airways obstruction and in control patients without any respiratory disorders (n =11) were compared in terms of estimates of the power spectrum. Breath sounds were recorded simultaneously at the chest and at the trachea.
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Computer assisted techniques for lung sound analysis1`6 have provided new data on the relationship between respiratory sounds and different pathophysiological conditions of the lung. By using these methods, changes in pulmonary and tracheal breath sounds as well as adventitious breath sounds -for example, wheezes and crackles -can be objectively and accurately recorded. In early studies Forgacs7 showed that breath sound intensity at the mouth was associated with forced expiratory volume in one second (FEVI) in patients with asthma and chronic obstructive bronchitis, but not in those with emphysema. Later it was shown that lung sound intensity is related to regional distribution of ventilation8 and is reduced primarily by airflow limitation in patients with emphysema.9 Spectral changes distinguishing the asthma patients from healthy subjects have been described.3`510 In addition, the frequency content of breath sounds was found to be dependent on the degree of bronchial obstruction during challenge tests, even in the absence of wheezing sounds."'-"
Standards for the diagnosis of obstructive pulmonary diseases are available. '4 In clinical and functional patterns there is a considerable overlap between asthma and chronic obstructive pulmonary disease (COPD), although the morphological and structural changes in the bronchi and lung parenchyma, as well as the site of these changes in the bronchial tree, are partly different.516 The different structural and morphological changes in COPD and asthma might be reflected in breath sounds.
At present there are few data available on the spectral characteristics of breath sounds in COPD, and no comparative data on the breath sounds of patients with asthma and COPD. The aim of the present study was to investigate the spectral characteristics of patients with COPD and stable asthma with significant airways obstruction under standardised conditions, and to compare them with those of sex and age matched control patients with healthy lungs.
Methods

PATIENTS
Thirty eight male outpatients referred to the Lung Function Laboratory at Helsinki University Central Hospital were selected for the study. Their anthropometric and lung function data are presented in table 1.
Seventeen patients had stable chronic obstructive pulmonary disease diagnosed previously according to ATS criteria'4; all were heavy current or ex-smokers. The degree of obstruction assessed by spirometric tests ranged from mild to very severe. None of the of the recorder was digitised in a data acquisition and control unit (HP 3852A) with 13-bit analogue-to-digital conversion; the sampling rate was 12 kHz for sound and 100 Hz for the airflow. A Bessel type low pass filter with a cut off frequency of 4 kHz (24 dB/oct) was used to prevent aliasing. The data from the flow and sound signals were stored on a magneto-optical disk of a Unix work station (HP 9000/330C). The sound signal was digitally high pass filtered (Kaiser-FIR) with a cut off frequency of 100 Hz (24 dB/oct).
The flow and sound signals were subsequently analysed on a computer by using custom made software based on Labview tool package. For the spectral analysis of sound signals 2048-point fast Fourier transforms were performed with 50% overlapping of adjacent Hanning data windows; the spectra were averaged over 8-10 consecutive breathing cycles by the method of Welch.'9 The effective frequency resolution of the spectral estimates was approximately 5 Hz. Only sound samples of inspiratory sounds that occurred at flows from 1-0/s to target flow (1 -25 /s) were used for calculation of averaged spectra. The average power spectra of background noise were similarly estimated from sound samples within a flow gate of 0 + 0-1/s. These spectra were used to evaluate the signal-to-noise ratio of the recordings. Expiratory sounds were not analysed because the breathing pattern could not be standardised among the patient groups due to expiratory flow limitation in some patients with asthma or COPD.
The upper frequency limits for the second quartile (F50, the median frequency) and the third (F75) quartile of the spectral power were calculated within a measuring band of 100-2000 Hz on the linear amplitude scale. The frequency of maximum intensity (Fmax) and the lung sound amplitude in terms of the root mean square (RMS) value of the total spectral power were also determined within the same measuring band.
The presence or absence of wheezes in the sound samples was evaluated by visual examination ofthe sound signal in time-expanded waveform analysis (1000 mm/s) and in frequency domain (FFT). The criteria for a wheeze were the presence of a sinusoidal waveform with a duration of more than 200 ms or an intensity peak distinctly separated from its surrounding intensity in the FFT spectrum. Within the inspiratory flow gate chosen for analysis (1-0-1-25 l/s) none of the patients was found to wheeze.
DATA ANALYSIS
The breath sound variables between the study groups were compared by the non-paired t test with the p values being adjusted for multiple comparison according to the Bonferroni equation (p*=pK; K=k(k-1)/2 where p* is the adjusted value of p and k is the number of groups).20 For correlative analysis within the groups, Pearson's correlation coefficient was calculated. A p value of less than 0-05 was considered significant.
Results
Examples ofphonopneumograms and averaged inspiratory spectra recorded at the chest in patients with asthma, COPD, and normal lungs are illustrated in fig 1. The spectra are calculated from sound samples at an airflow gate of 1 -0-1-25 1/s. In each spectrum plotted on a log-log scale the F50 is indicated and the background spectra (sound at 0 +0-1 /s flow) presented. The expiratory flow profiles differed between the patients with different diagnoses as shown in fig 1, but inspiratory flow profiles appeared quite similar. The spectra in fig 1 are smooth in shape without irregularities or peaks that could indicate wheezing sounds. The spectrum of the asthma patient is broader in shape, indicating increased sound energy at a frequency range of 200-1000 Hz; consequently, the F50 is increased compared with that of the control patient. In the patient with COPD the attenuation of the sound power is more gradual over the whole frequency range, but the global frequency distribution in terms of F50 is not significantly different from that of the control patient. In the whole group of patients with COPD we did not find any characteristic spec- 
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The total spectral power record( chest in terms of RMS was higher in a than in patients with COPD. Othei not explained by differences in the severity of airways obstruction. High quality equipment was used for recording of breath sounds.6 Different microphones were used at the trachea and at the chest for anatomical reasons so the sound spectra cannot be critically compared between the two locations. It should be noted that the frequency characteristics of the microphones,27 and specifically the dimensions of the air coupling cavity," have been shown to modify the shape of lung sound spectra. With the present condenser microphone of 5 mm cavity depth some high frequency components may therefore have been attenuated in the chest wall recordings. However, the same microphones were used for all patients and their characteristics cannot therefore explain the differences among the patient groups.
The frequency spectra were averaged to minimise the effect of random noise. A cutoff frequency level of 100 Hz was chosen to eliminate the muscular29 and cardiovascular30 sounds from the respiratory sound analysis. Calculation of background noise enabled us to evaluate the signal-to-noise ratio of the sound. The background spectra were not subtracted from the analysed breath sound spectra because relevant information may have been lost for two reasons. Firstly, the background spectra were derived under dynamic conditions (during breathing with flows up to + 0.01 l/s) and inevitably contained a small contribution of lung sounds. Secondly, in some individuals there were insufficient data points to create an accurate estimate from the background spectrum (even if the level of signal-to-noise ratio could be estimated). We believe that, if subtraction of background noise is preferred, sound during breath holding should be used.3' Our preference to use background noise at zero flow as quality control is the same as that ofPasterkamp et al. 27 The same recording room and conditions were used for every patient so the ambient noise during recordings did not vary significantly from patient to patient.
The flow at the mouth was carefully controlled during lung sound recordings so that inspiratory tidal peak flow and pattern were similar in the patient groups. The spectral shape has been shown to be quite stable at high flow rates above 1'0 I/s,3233 but to be dependent on flow at low flow rates.310 Flow gated sampling of respiratory sounds was originally described by O'Donnel and Kraman.34 In this study we used only sound samples of a defined inspiratory flow gate (1I0-1 -25 U/s) for the spectral analysis, ensuring that breath sound spectra among the patient groups were derived from exactly the same flows. Differences in airflow or breathing pattern cannot therefore explain the differences in frequency distribution oflung sounds among the patient groups. Since only inspiratory breath sounds were analysed, expiratory flow limitation occurring in some patients with COPD did not influence the results. In contrast, clear differences in expiratory flow patterns did not allow valid comparison of expiratory breath sounds so the latter were not included in the study.
Compared with control and COPD patients, the different frequency content of breath sounds in the asthmatics was reflected in changes in F50, F75, and the total spectral power. The presence of adventitious lung sounds such as wheezes and crackles could change these spectral indices, but there were no wheezing sounds during the inspiratory sound samples selected for analysis. Crackling sounds were not counted, but on visual examination appeared to be rare in our patients with COPD. Furthermore, the averaging method used is relatively insensitive to non-stationary changes of breath sounds such as crackles. It is therefore unlikely that adventitious breath sounds would have markedly contributed to the changes observed in averaged frequency spectra.
It may be argued that the present parameters chosen to characterise the breath sound spectra (RMS, Fmax, and the quartiles) are not sufficient as they do not provide specific information about the pattern of the spectral curve. However, they have been widely used in clinical studies of breath sounds in asthma'0 11 13 and, in particular, the quartiles give an estimate of the global frequency distribution of breath sounds, the primary interest of our study.
Normal tracheal sounds are characterised by a broad spectrum of frequencies with a sharp decrease ofpower above 800-1600 Hz. Normal vesicular lung sounds in the chest contain a spectrum of frequencies up to approximately 500 Hz; the frequency components of lung sounds above this are effectively filtered by the lung tissue and the chest wall. 35 In normal men inspiratory sounds containing substantial power relative to background noise up to 2000 Hz have been reported when high airflow rates are used (up to 2-5 l/s).27 In the present study the usual frequency range at which the background noise was reached in chest recordings was 1 0-1 2 kHz. However, the target flow was set at a relatively low level (1I 25 l/s) due to the reduced ventilatory function in patients with asthma and COPD.
In previous studies the frequency spectra of asthmatics were found to differ from those of healthy controls during episodes ofwheezing. 3 In patients with acute asthma the proportion of the respiratory cycle occupied by wheezing was found to correlate with FEVI.36 In previous studies on asthmatics during challenge tests the frequency distribution of breath sounds was shown to be related to the degree of bronchial obstruction, with higher F50 values being found during bronchial obstruction11-3 and also in the absence of wheezing sounds. Schreur et all' recently found similar changes in frequency distribution of lung sounds in asthma patients even with normal lung function. The present finding that sound energy is shifted towards higher frequencies in asthmatics compared with controls is in accordance with previously reported studies.
In the previous literature there are only few data available about the spectral characteristics of breath sounds in COPD. Gavriely et al37 used lung sound analysis for respiratory health screening and found that 30 out of 62 subjects with clinical COPD had abnormal breath sound spectra. They used regression analysis of the spectral curve to define abnormality, which is a particularly useful method to detect curve irregularities caused by wheezing sounds. The quartile frequencies were not used in this study, and the patterns of abnormalities in COPD were not compared with those in asthma. In our study flow standardised inspiratory breath sounds that did not contain wheezes did not differ between COPD and control patients, but in asthmatic patients significantly higher RMS, F50 and F75 values were found than in patients with COPD. The spectral shapes did not differ visually between patients with COPD and control patients, and the frequency range that contained breath sounds with substantial power relative to background spectra was about the same in the two groups. However, the frequency content of inspiratory vesicular lung sounds in patients with COPD seemed to be affected by the presence of emphysema, patients with reduced Kco having lower F50 values.
It has been shown that the auscultatory finding of damped breath sounds in patients with emphysema is predominantly due to airflow limitation, and that at standardised airflows the breath sound intensity is similar in patients with emphysema and healthy controls.9 The RMS values in the present study were calculated from the power spectrum and are not therefore equivalent to breath sound intensity. However, our finding that the total spectral power did not differ between the COPD patients and controls was consistent with the previous literature. During episodes of normal lung function in asthmatic patients Schreur et allo found that, at a given airflow, expiratory sounds were lower in intensity than those of the healthy controls. In contrast, they did not find any difference in inspiratory sound intensity between their study groups as we did between the control patients and asthmatic patients with airways obstruction.
The generally accepted view is that vesicular lung sounds are generated predominantly by turbulence in the larger airways (main, lobar, and segmental bronchi) and transmitted from these locations to the chest wall.2" The calculations from gas density, viscosity, and velocity predict laminar and, presumably, soundless flow in more peripheral airways. However, there is experimental evidence to show that at least the inspiratory portion of vesicular lung sounds is produced locally in small airways by non-turbulent mechanisms.38
In asthmatic patients the increase in frequency content of breath sounds during bronchoconstriction can be explained by the local increase of flow velocity through the narrowed bronchi which results in increased kinetic energy and turbulence, characterised by a higher pitch sound.39 According to the model of unstable vortices by Hardin and Patterson40 the sound frequency produced is inversely related to the diameter of the airways at a given mass flow; higher sound frequencies are thus expected to be found in asthmatics with narrowed airways. The present finding that the F5,, is significantly correlated with FEV, in asthmatic patients also indicates the close relationship between frequency distribution of breath sounds and narrowing of the airways.
The present results indicate that, in patients with COPD, the vesicular lung sounds are either unchanged in spite of airway narrowing or some other mechanisms are involved that counteract the effect of increased turbulence in the bronchi. The sound generation in asthma and COPD may be different since the structural changes in the bronchi in patients with COPD are situated more peripherally in small airways where turbulence does not occur in normal conditions. The trend between Kco and F50 of inspiratory lung sounds in COPD suggests that the sound is affected by the degree of emphysema. The lung parenchyma and the chest wall act like a band pass filter. The average density of lung tissue is reduced in emphysema due to tissue destruction; this should affect the transmission of lung sounds from their source to the chest wall22 and accentuate the low pass filtration effect of the thorax. Consequently, lower frequency lung sounds would be detected at the chest, a possible explanation for the difference between asthma and COPD.
Breath sounds heard at the trachea are presumably generated in the very central airways by turbulent mechanisms, and the larynx may also contribute to the sound production by acting as a nozzle, creating a jet of air.2' The correlation between FEV, and F50 in asthmatic patients may relate to increased turbulence in central airways, probably caused by airway narrowing. The frequency distribution oftracheal sounds has high intersubject variation which relates to individual resonant frequencies with accentuated intensities. Thus, significant differences between the patient groups could not be found for tracheal sounds.
The finding that breath sound spectral patterns in patients with COPD and asthma differ significantly may have also clinical implications, since it provides new tools for differential diagnosis of obstructive lung disorders. In the present study, however, the F50 values in asthma and in COPD partly overlapped, and the specificity of a given F50 value is probably not very high. Further studies may reveal other spectral estimators that could be used to separate the groups more effectively.
In conclusion, the present findings indicate that the frequency spectra of breath sounds in patients with stable asthma, but not in patients with COPD, differ significantly from those in patients with healthy lungs. It is postulated that the structural changes in the bronchi and in the surrounding lung tissue in COPD and asthma result in different breath sound generation or transmission. Breath sound spectral analysis may provide a new non-invasive method for differential diagnosis of bronchial obstruction. 
